SANUWAVE director receives 3,208 stock options

SANUWAVE Health, Inc. director Tyler James reported receiving a grant of stock options.

Rhea-AI Filing Summary

SANUWAVE Health, Inc. director Tyler James reported receiving a grant of stock options. The award covers 3,208 options, each giving the right to buy one share of common stock at an exercise price of $17.29 per share. According to the filing, these options were fully vested on the grant date and expire on March 31, 2031. Following this grant, James holds 3,208 stock options directly, with no common stock purchases or sales reported in this filing.

Insights

Equity compensation analyst

Routine, fully vested option grant to a director; no buy/sell signal.

Director Tyler James received a grant of 3,208 stock options for SANUWAVE Health, Inc. The options have a strike price of $17.29 and expire on March 31, 2031. Footnotes state the options were fully vested when granted, indicating immediate exercisability.

This is a standard equity compensation event categorized as a grant, award, or other acquisition, not an open‑market trade. With no common share purchases or sales and total derivative holdings now 3,208 options, this filing mainly documents director compensation rather than a directional view on the stock.

Insider Trade Summary

Grant/Award: 3,208 shares

Grant/Award 1 txn

Insider Tyler James

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	3,208	$0.00	$0.00

Holdings After Transaction: Stock Option (right to buy) — 3,208 contracts (Direct)

Footnotes (1)

1. F1. Options were fully vested at the grant date.

Key Figures

Options granted: 3,208 options Exercise price: $17.29 per share Expiration date: March 31, 2031 +2 more

5 metrics

Options granted 3,208 options Stock Option (right to buy) grant to director Tyler James

Exercise price $17.29 per share Strike price for the 3,208 stock options

Expiration date March 31, 2031 Option term for the reported grant

Underlying shares 3,208 shares Common stock underlying the option award

Post-grant derivative holdings 3,208 options Total stock options held directly after this transaction

Key Terms

Stock Option (right to buy), Grant, award, or other acquisition, fully vested, underlying security

4 terms

Stock Option (right to buy) financial

"security_title: "Stock Option (right to buy)""

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

fully vested financial

"Footnote: "Options were fully vested at the grant date.""

underlying security financial

"underlying_security_title: "Common Stock""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did SANUWAVE (SNWV) director Tyler James report in this Form 4?

Director Tyler James reported receiving a grant of 3,208 stock options in SANUWAVE Health, Inc. The options are fully vested, give the right to buy common stock at $17.29 per share, and represent equity compensation rather than an open-market purchase or sale.

How many SANUWAVE (SNWV) stock options did Tyler James receive?

Tyler James received 3,208 stock options. Each option corresponds to one share of SANUWAVE common stock. This grant increased his directly held derivative position to 3,208 options, with no additional exercises, purchases, or sales disclosed in this particular Form 4 filing.

What is the exercise price and expiration date of Tyler James’s SANUWAVE options?

The options granted to Tyler James have an exercise price of $17.29 per share and expire on March 31, 2031. This means he can choose to buy SANUWAVE common stock at $17.29 any time before that expiration date, subject to the plan’s terms.

Were Tyler James’s SANUWAVE stock options vested at grant?

Yes. A footnote states the options were fully vested at the grant date. Full vesting at grant means James did not need to satisfy additional service or performance conditions before being able to exercise these options under the applicable equity plan.

Does this SANUWAVE (SNWV) Form 4 show any stock being bought or sold on the market?

No. The Form 4 reports a grant of stock options categorized as a grant, award, or other acquisition. It does not disclose any open-market purchases or sales of SANUWAVE common shares, only the new option award to director Tyler James.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/02/2026 - 05:10 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tyler James

(Last) (First) (Middle)

9600 W. 76TH STREET

SUITE 118

(Street)

EDEN PRAIRIE MINNESOTA 55344

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
SANUWAVE Health, Inc. [ SNVW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$17.29	03/31/2026		A		3,208		(1)	03/31/2031	Common Stock	3,208	$0	3,208	D

Explanation of Responses:

1. Options were fully vested at the grant date.

	/s/ Griffin D. Foster, Attorney-in-Fact for James Tyler	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)